Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_1
1
17%
Ph phase_3
1
17%
Ph phase_2
3
50%

Phase Distribution

1

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Recruiting1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 23 (50.0%)
Phase 31 (16.7%)
N/A1 (16.7%)

Trials by Status

recruiting117%
withdrawn117%
completed350%
terminated117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingnot_applicable

FMT in Initial CDI

NCT05257538
terminatedphase_1

Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT)

NCT04032717
withdrawnphase_2

FMT for Remission of Active Ulcerative Colitis in Adults

NCT04202211
completedphase_2

Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis

NCT01149707
completedphase_3

An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase

NCT02368717
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05257538Not Applicable

FMT in Initial CDI

Recruiting
NCT04032717Phase 1

Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT)

Terminated
NCT04202211Phase 2

FMT for Remission of Active Ulcerative Colitis in Adults

Withdrawn
NCT01149707Phase 2

Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis

Completed
NCT02368717Phase 3

An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase

Completed
NCT01545908Phase 2

Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis

Completed

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6